Skip to main content Back to Top
Advertisement

9/17/2019

Tropicamide 1% Ophthalmic Solution

Products Affected - Description

    • Tropicamide ophthalmic solution, Akorn, 1%, 15 mL bottle, 1 count, NDC 17478-0102-12

Reason for the Shortage

    • Akorn did not provide a reason for the shortage of tropicamide 1% ophthalmic drops.
    • Alcon has Mydriacyl available.
    • Bausch Health discontinued tropicamide 1% ophthalmic drops in mid-2018.
    • Sandoz has tropicamide 1% ophthalmic drops available.

Available Products

    • Mydriacyl ophthalmic solution, Alcon Labs, 1%, 15 mL bottle, 1 count, NDC 00065-0355-15
    • Tropicamide ophthalmic solution, Sandoz, 1%, 15 mL bottle, 1 count, NDC 61314-0355-02
    • Tropicamide ophthalmic solution, Sandoz, 1%, 3 mL bottle, 1 count, NDC 61314-0355-01

Estimated Resupply Dates

    • Akorn has tropicamide 1% ophthalmic drops in 15 mL bottles on allocation.

Updated

Updated September 17, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 20, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins